Dementia Clinical Trials in New Haven, Connecticut

4 studies are recruiting for dementia in New Haven, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

    PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the …

    Stage
    Phase 4
    Ages
    75 and older
    Site
    Yale University, New Haven, Connecticut
    Locations
    106 in total
    Run by
    Duke University

    See if you can join NCT04262206 on ClinicalTrials.gov

  2. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    The purpose is to evaluate the biomarker effect, safety, and tolerability of investigational study drugs in participants who are known to have an Alzheimer's disease (AD)-causing mutation. Stage 1 will determine if treatment with the study drug prevents or slows the rate of amyloid beta (Aβ) pathol…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Yale University School of Medicine, New Haven, Connecticut
    Locations
    37 in total
    Run by
    Washington University School of Medicine

    See if you can join NCT05552157 on ClinicalTrials.gov

  3. A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    The purpose of this research study is to test the study drug, referred to as remternetug, to determine its effectiveness for the study treatment of asymptomatic (at risk) Alzheimer disease in individuals with AD-causing mutations. This study will also investigate the effects of remternetug on bioma…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Yale University School of Medicine, New Haven, Connecticut
    Locations
    37 in total
    Run by
    Washington University School of Medicine

    See if you can join NCT06647498 on ClinicalTrials.gov

  4. Music for Pain and Dementia

    This study aims to provide mechanistic insights into how group drumming as a music-based intervention (MBI) affects pain responses and nociceptive function in individuals with Alzheimer's Disease (AD), mild dementia or mild cognitive impairment (MCI). Heart rate (HR), heart rate variability (HRV), …

    Stage
    Not phased
    Ages
    50 to 80
    Site
    Connecticut Mental Health Clinic, New Haven, Connecticut
    Run by
    Yale University

    See if you can join NCT07602283 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.